Ability of structurally diverse natural products and synthetic chemicals to induce gene expression mediated by estrogen receptors from various species

Journal of Steroid Biochemistry and Molecular Biology

Volumn 82, Issue 2-3, 2002, Pages 181-194

  Matthews, J B ^a,c   Fertuck, K C ^a   Celius, T ^a   Huang, Y W ^a,b   Fong, C J ^a   Zacharewski, T R ^a  

^a Michigan State University   (United States)

^b MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

EED; Estrogen; Species

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 4 OCTYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ALPHA ZEARALENOL; ATRAZINE; BETA ZEARALENOL; COUMESTROL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; METHOXYCHLOR; NARINGENIN; NATURAL PRODUCT; SITOSTEROL;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DOSE RESPONSE; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DOMAIN; REPORTER GENE; SPECIES COMPARISON;

ANIMALS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; ESTROGENS, NON-STEROIDAL; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MOLECULAR STRUCTURE; NUCLEAR RECEPTOR COACTIVATOR 2; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; STATISTICS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANOLIS CAROLINENSIS; GALLUS GALLUS; MINK CELL FOCUS-FORMING VIRUS; ONCORHYNCHUS MYKISS; SALMONIDAE; VERTEBRATA;

EID: 0036816666     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00159-0     Document Type: Article

References (62)

1. McLachlan J.A., Korach K.S. Symposium on estrogens in the environment, III. Environ. Health. Perspect. 103(Suppl. 7):1995;3-4.
2. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101:1993;378-384.
3. Harrison P.T., Holmes P., Humfrey C.D. Reproductive health in humans and wildlife: are adverse trends associated with environmental chemical exposure? Sci. Total Environ. 205:1997;97-106.
4. McLachlan J.A. Functional toxicology: a new approach to detect biologically active xenobiotics. Environ. Health Perspect. 101:1993;386-387.
5. Safe S.H. Endocrine disruptors and human health - is there a problem? An update. Environ. Health Perspect. 108:2000;487-493.
6. Katzenellenbogen J.A. The structural pervasiveness of estrogenic action. Environ. Health Perspect. 103(Suppl. 7):1995;99-101.
7. Adlercreutz H., Hockerstedt K., Bannwart C., Bloigu S., Hamalainen E., Fotsis T., Ollus A. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J. Steroid Biochem. 27:1987;1135-1144.
8. Hodgert Jury H., Zacharewski T.R., Hammond G.L. Interactions between human plasma sex hormone-binding globulin and xenobiotic ligands. J. Steroid. Biochem. Mol. Biol. 75:2000;167-176.
9. Chen S., Kao Y.C., Laughton C.A. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase. J. Steroid Biochem. Mol. Biol. 61:1997;107-115.
10. Kao Y.C., Zhou C., Sherman M., Laughton C.A., Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ. Health Perspect. 106:1998;85-92.
11. Sanderson J.T., Seinen W., Giesy J.P., van den Berg M. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity? Toxicol. Sci. 54:2000;121-127.
12. Loomis A.K., Thomas P. Effects of estrogens and xenoestrogens on androgen production by Atlantic croaker testes in vitro: evidence for a nongenomic action mediated by an estrogen membrane receptor. Biol. Reprod. 62:2000;995-1004.
13. Revelli A., Massobrio M., Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endo. Rev. 19:1998;3-17.
14. Blumberg B., Sabbagh W. Jr., Juguilon H., Bolado J.C.M. Jr., Ong E.S., Evans R.M. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes. Dev. 12:1998;3195-3205.
15. Moore J.T., Kliewer S.A. Use of the nuclear receptor PXR to predict drug interactions. Toxicology. 153:2000;1-10.
16. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
17. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
18. Mosselman S., Polman J., Dijkema R. ERb: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392:1996;49-53.
19. Matthews J., Celius T., Halgren R., Zacharewski T. Differential estrogen receptor binding of estrogenic substances: a species comparison. J. Steroid Biochem. Mol. Biol. 74:2000;223-234.
20. Matthews J., Zacharewski T. Differential binding affinities of PCBs, HO-PCBs, and Aroclors with recombinant human, rainbow trout (Onchorhynkiss mykiss), and green anole (Anolis carolinensis) estrogen receptors, using a semi-high throughput competitive binding assay. Toxicol. Sci. 53:2000;326-339.
21. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes. Dev. 14:2000;121-141.
22. Glass C.K., Rose D.W., Rosenfeld M.G. Nucl. receptor co-activators. Curr. Opin. Cell. Biol. 9:1997;222-232.
23. Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., O'Malley B.W. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 273:1998;12101-12108.
24. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 264:1994;1455-1458.
25. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell Biol. 17:1997;2735-2744.
26. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 1996:1996;3667-3675.
27. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
28. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580.
29. Takeshita A., Cardona G.R., Koibuchi N., Suen C.S., Chin W.W. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272:1997;27629-27634.
30. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear receptor function. Nature. 387:1997;677-684.
31. An J., Tzagarakis-Foster C., Scharschmidt T.C., Lomri N., Leitman D.C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem. 276:2001;17808-17814.
32. Bramlett K.S., Wu Y., Burris T.P. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol. Endocrinol. 15:2001;909-922.
33. Routledge E.J., White R., Parker M.G., Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and Erbeta. J. Biol. Chem. 275:2000;35986-35993.
34. Andersen H.R., Andersson A.M., Arnold S.F., Autrup H., Barfoed M., Beresford N.A., Bjerregaard P., Christiansen L.B., Gissel B., Hummel R., Jorgensen E.B., Korsgaard B., Le Guevel R., Leffers H., McLachlan J., Moller A., Nielsen J.B., Olea N., Oles-Karasko A., Pakdel F., Pedersen K.L., Perez P., Skakkeboek N.E., Sonnenschein C., Soto A.M.et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect. 107(Suppl. 1):1999;89-108.
35. Fitzpatrick D.W., Picken C.A., Murphy L.C., Buhr M.M. Measurement of the relative binding affinity of zearalenol, α-zearalenol and β-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies. Comp. Biochem. Physiol. 94C:1989;691-694.
36. Petit F., Valotaire Y., Pakdel F. Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae. Eur. J. Biochem. 233:1995;584-592.
37. Matthews J.B., Twomey K., Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 14:2001;149-157.
38. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18:1999;4608-4618.
39. Strunck E., Stemmann N., Hopert A., Wunsche W., Frank K., Vollmer G. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 74:2000;73-81.
40. Zenke M., Munoz A., Sap J., Vennstrom B., Beug H. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity. Cell. 61:1990;1035-1049.
41. Fertuck K.C., Matthews J.B., Zacharewski T.R. Hydroxylated benzo[a]pyrene metabolites are responsible for in vitro estrogen receptor-mediated gene expression induced by benzo[a]pyrene, but do not elicit uterotrophic effects in vivo. Toxicol. Sci. 59:2001;231-240.
42. Fertuck K.C., Kumar S., Sikka H.C., Matthews J.B., Zacharewski T.R. Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor. Toxicol. Lett. 121:2001;167-177.
43. Matthews J.B., Clemons J.H., Zacharewski T.R. Reciprocal mutagenesis between human alpha (L349, M528) and rainbow trout (M317, I496) estrogen receptor residues demonstrates their importance in ligand binding and gene expression at different temperatures. Mol. Cell Endocrinol. 183:2001;127-139.
44. Gillesby B.E., Zacharewski T.R. pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers. Breast Cancer Res. Treat. 56:1999;253-265.
45. Matthews J.B., Zacharewski T. Differential binding affinities of PCBs, HO-PCBs, and Aroclors with recombinant human, rainbow trout (Onchorhynkiss mykiss), and green anole (Anolis carolinensis) estrogen receptors, using a semi-high throughput competitive binding assay. Toxicol. Sci. 53:2000;326-339.
46. Zacharewski T. In vitro assays used to assess estrogenic substances. Environ. Sci. Tech. 31:1997;613-623.
47. Clemons J.H., Allan L., Marvin C.R., Wu Z.F., McCarry B.E., Bryant D.W., Zacharewski T.R. Identification of estrogen- and dioxin-like activities in urban air particulate matter using recombinant receptor/reporter gene bioassays. Environ. Sci. Technol. 32:1998;1853-1860.
48. Petit F.G., Valotaire Y., Pakdel F. The analysis of chimeric human/rainbow trout estrogen receptors reveals amino acid residues outside of P- and D-boxes important for the transactivation function. Nucl. Acids Res. 28:2000;2634-2642.
49. Pakdel F., Le Gac F., Le Goff P., Valotaire Y. Full-length sequence and in vitro expression of rainbow trout estrogen receptor cDNA. Mol. Cell Endocrinol. 71:1990;195-204.
50. Reese J.C., Katzenellenbogen B.S. Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor. Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation. J. Biol. Chem. 267:1992;9868-9873.
51. Mellanen P., Petanen T., Lehtimaki J., Makela S., Bylund G., Holmbom B., Mannila E., Oikaro A., Santti R. Wood-derived estrogens: studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol. Appl. Pharmacol. 136:1996;381-388.
52. Benhamou B., Garcia T., Lerouge T., Vergezac A., Gofflo D., Bigogne C., Chambon P., Gronemeyer H. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science. 255:1992;206-209.
53. Govindan M.V. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor. Mol. Endocrinol. 4:1990;417-427.
54. Takada I., Yu R.T., Xu H.E., Lambert M.H., Montana V.G., Kliewer S.A., Evans R.M., Umesono K. Alteration of a single amino acid in peroxisome proliferator-activated receptor-alpha (PPAR alpha) generates a PPAR delta phenotype. Mol. Endocrinol. 14:2000;733-740.
55. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852.
56. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4263.
57. Charles G.D., Bartels M.J., Zacharewski T.R., Gollapudi B.B., Freshour N.L., Carney E.W. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. Toxicol. Sci. 55:2000;320-326.
58. Gaido K.W., Leonard L.S., Maness S.C., Hall J.M., McDonnell D.P., Saville B., Safe S. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology. 140:1999;5746-5753.
59. Gaido K.W., Maness S.C., McDonnell D.P., Dehal S.S., Kupfer D., Safe S. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol. Pharmacol. 58:2000;852-858.
60. Waters K.M., Safe S., Gaido K.W. Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol. Sci. 63:2001;47-56.
61. Shelby M.D., Newbold R.R., Tully D.B., Chae K., Davis V.L. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ. Health Perspect. 104:1996;1296-1300.
62. Celius T., Matthews J.B., Giesy J.P., Zacharewski T.R. Quantification of rainbow trout (Oncorhynchus mykiss) zona radiata and vitellogenin mRNA levels using real-time PCR after in vivo treatment with estradiol-17 beta or alpha-zearalenol. J. Steroid Biochem. Mol. Biol. 75:2000;109-119.